Researchers explore the effects of a dietary intervention in postpartum women with higher body mass index.
Updated: Alnylam delays highly-anticipated ATTR readout as it changes study design
Alnylam is making a series of changes to a closely-watched study of its ATTR amyloidosis drug vutrisiran that will delay the Phase III readout from